3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sleep Initiation and Maintenance Disorders
19
Breast Neoplasms
14
Neoplasms
12
Anxiety Disorders
7
Prostatic Neoplasms
6
Depression
5
Motor Activity
3
Lymphoma
3
Weight Loss
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Multiple Myeloma
2
Lung Neoplasms
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Interventions
Morphine
11
Oxycodone
8
Fentanyl
6
nabiximols
5
Methadone
4
Hydromorphone
4
Acetaminophen
3
Transcutaneous Electric Nerve Stimulation
2
Tapentadol
2
Naloxone
2
Lidocaine
2
Buprenorphine
2
Acupuncture Therapy
2
tanezumab
1
resiniferatoxin
1
oxycodone naloxone combination
1
fulranumab
1
cannabichromene
1
alvimopan
1
Water
1
Ultracet
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Therapeutic Touch
1
Telemedicine
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cancer Pain
×
Cognitive Behavioral Therapy
×
Clear all
NCT05774197
2025-11-04
STAMP+CBT
University of Oklahoma
Phase NA
Completed
52 enrolled
7 charts